Inventor · disambiguated record
Andrew M. Petros
Also filed as: PETROS ANDREW · PETROS ANDREW M
19 granted patents·4 pending applications·875 citations·filing 2000–2017
96Inventor score
Top patents by PatentIndex Score
23 records- 0198US7973161B2Apoptosis promotersABBOTT LAB·Filed 2006·Granted Jul 5, 2011·70 cites·5 claims
- 0298US7767684B2Apoptosis promotersABBOTT LAB·Filed 2005·Granted Aug 3, 2010·107 cites·7 claims
- 0398US7642260B2Apoptosis promotersABBOTT LAB·Filed 2005·Granted Jan 5, 2010·82 cites·2 claims
- 0498US6720338B2N-acylsulfonamide apoptosis promotersABBOTT LAB·Filed 2001·Granted Apr 13, 2004·98 cites·9 claims
- 0597US8586754B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2010·Granted Nov 19, 2013·59 cites·8 claims
- 0697US8563735B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2009·Granted Oct 22, 2013·72 cites·4 claims
- 0797US8354404B2Apoptosis promotersABBOTT LAB·Filed 2011·Granted Jan 15, 2013·39 cites·8 claims
- 0897US8173811B2Apoptosis promotersBRUNCKO MILAN·Filed 2010·Granted May 8, 2012·50 cites·4 claims
- 0997US7754886B2N-acylsulfonamide apoptosis promotersABBOTT LAB·Filed 2009·Granted Jul 13, 2010·34 cites·18 claims
- 1097US7504512B2N-acylsulfonamide apoptosis promotersABBOTT LAB·Filed 2004·Granted Mar 17, 2009·58 cites·18 claims
- 1196US8614318B2Apoptosis promotersBRUNCKO MILAN·Filed 2006·Granted Dec 24, 2013·37 cites·2 claims
- 1296US8084607B2Apoptosis promotersBRUNCKO MILAN·Filed 2009·Granted Dec 27, 2011·43 cites·5 claims
- 1395US8114893B2Compounds and methods of useBAELL JONATHAN BAYLDON·Filed 2009·Granted Feb 14, 2012·43 cites·20 claims
- 1493US8518970B2Compounds and methods of useBAELL JONATHAN BAYLDON·Filed 2012·Granted Aug 27, 2013·29 cites·25 claims
- 1592US8232273B2Heterocyclic compounds and methods of useBAELL JONATHAN BAYLDON·Filed 2009·Granted Jul 31, 2012·28 cites·31 claims
- 1690US9072748B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jul 7, 2015·11 cites·10 claims
- 1789US9125913B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Sep 8, 2015·10 cites·6 claims
- 1882US9067928B2Compounds and methods of useGENENTECH INC·Filed 2013·Granted Jun 30, 2015·5 cites·24 claims
- 1969US2010160322A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBOTT LAB·Filed 2009·Application pending·0 cites
- 2061US2018251426A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2017·Application pending·0 cites
- 2154US2005159427A1N-acylsulfonamide apoptosis promotersFiled 2004·Application pending·0 cites
- 2248US7226992B1Mutant Bcl-2 proteins and uses thereofABBOTT LAB·Filed 2000·Granted Jun 5, 2007·0 cites·1 claims
- 2336US2002055631A1N-acylsulfonamide apoptosis promotersFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew M. Petros files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →